marketcaparena
Search

    IRMD

    IRADIMED CORP

    Company overview

    Market capitalization
    $1.11B
    Employees
    166
    Latest publication
    2026-09-29
    About IRADIMED CORP

    IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue20,466,000USD21,979,000USD22,692,000USD21,202,064USD20,409,400USD19,510,637USD19,389,167USD18,325,959USD
    Cost Of Revenue5,306,000USD5,165,000USD5,660,000USD4,707,756USD4,454,408USD4,667,831USD4,628,308USD4,134,253USD
    Gross Profit15,160,000USD16,814,000USD17,032,000USD16,494,308USD15,954,992USD14,842,806USD14,760,859USD14,191,706USD
    Research Development657,000USD956,000USD799,000USD674,362USD877,362USD624,245USD569,993USD639,467USD
    Selling And Marketing Expenses4,246,000USD4,052,000USD4,604,000USD4,630,560USD4,009,640USD4,176,273USD4,517,497USD3,795,320USD
    General And Administrative Expenses3,866,000USD———————
    Total Operating Expenses8,769,000USD9,577,000USD9,938,000USD9,660,558USD9,166,995USD9,411,350USD8,960,642USD8,402,586USD
    Operating Income6,391,000USD7,237,000USD7,094,000USD6,833,750USD6,787,997USD5,431,456USD5,800,217USD5,789,120USD
    Total Other Income Expense Net497,000USD532,000USD697,000USD463,976USD539,247USD513,973USD544,160USD629,201USD
    Income Before Tax6,888,000USD7,769,000USD7,791,000USD7,297,726USD7,327,244USD5,945,429USD6,344,377USD6,418,321USD
    Income Tax Expense1,670,000USD1,951,000USD1,349,000USD1,721,074USD1,553,283USD1,258,000USD1,197,599USD1,368,830USD
    Net Income5,218,000USD5,818,000USD6,442,000USD5,576,652USD5,773,961USD4,687,429USD5,146,778USD5,049,491USD
    Selling General Administrative—4,569,000USD4,535,000USD4,355,636USD4,279,993USD4,610,832USD3,873,152USD3,967,799USD
    Tax Provision—1,951,000USD1,348,643USD1,721,074USD1,553,283USD1,258,000USD1,197,599USD1,368,830USD
    Net Income From Continuing Ops—5,818,000USD6,441,958USD5,576,652USD5,773,961USD4,687,429USD5,146,778USD5,049,491USD
    Ebit—7,769,000USD7,791,000USD7,297,726USD7,327,247USD5,945,429USD6,344,377USD6,418,321USD
    Ebitda—8,224,000USD8,405,000USD7,681,448USD7,919,699USD6,139,551USD6,539,243USD6,615,892USD
    Depreciation And Amortization—455,000USD614,000USD383,722USD592,452USD194,122USD194,866USD197,571USD
    Reconciled Depreciation—455,000USD380,680USD383,722USD207,476USD194,122USD194,866USD197,571USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue83,814,000USD73,242,121USD65,562,296USD53,303,145USD41,814,581USD31,717,372USD38,517,141USD30,438,983USD
    Cost Of Revenue19,490,000USD16,892,240USD15,404,027USD12,020,742USD9,764,656USD8,142,962USD8,816,161USD7,211,633USD
    Gross Profit64,324,000USD56,349,881USD50,158,269USD41,282,403USD32,049,925USD23,574,410USD29,700,980USD23,227,350USD
    Research Development2,975,000USD2,831,589USD2,858,656USD2,278,081USD1,905,043USD1,902,530USD1,432,719USD1,517,112USD
    Selling General Administrative17,782,000USD15,937,123USD15,122,065USD10,697,067USD9,771,462USD12,269,079USD10,451,266USD8,710,882USD
    Selling And Marketing Expenses17,420,000USD15,616,442USD12,142,090USD12,679,610USD10,555,738USD10,158,892USD9,169,590USD6,995,586USD
    Total Operating Expenses38,177,000USD34,385,154USD30,122,811USD25,654,758USD22,232,243USD24,330,501USD21,053,575USD17,223,580USD
    Operating Income26,147,000USD21,964,727USD20,035,458USD15,627,645USD9,817,682USD-756,091USD8,647,405USD6,003,770USD
    Interest Income2,009,000USD2,193,145USD1,864,113USD581,852USD34,806USD132,185USD388,801USD238,106USD
    Net Interest Income2,009,000USD2,193,145USD1,864,113USD581,852USD34,806USD132,185USD388,801USD238,106USD
    Income Before Tax28,361,000USD24,275,459USD21,738,256USD16,180,749USD9,836,287USD-616,878USD9,043,317USD6,197,307USD
    Income Tax Expense5,881,000USD5,041,433USD4,545,480USD3,353,348USD510,816USD-1,985,879USD-587,642USD-106,143USD
    Tax Provision5,881,000USD5,041,433USD4,433,484USD3,353,348USD510,816USD-1,985,879USD-587,642USD-106,143USD
    Net Income22,480,000USD19,234,026USD17,192,776USD12,827,401USD9,325,471USD1,369,001USD9,630,959USD6,303,450USD
    Net Income From Continuing Ops22,480,000USD19,234,026USD16,326,707USD12,827,401USD9,325,471USD1,369,001USD9,630,959USD6,303,450USD
    Ebit28,361,000USD24,275,459USD20,035,458USD15,627,645USD9,836,287USD-756,091USD8,647,405USD6,549,045USD
    Ebitda30,741,000USD25,093,115USD20,035,458USD16,298,318USD11,243,110USD582,733USD9,889,730USD7,108,773USD
    Depreciation And Amortization2,380,000USD817,656USD-2USD670,673USD1,406,823USD1,338,824USD1,242,325USD559,728USD
    Reconciled Depreciation1,166,000USD817,656USD-133,100USD670,673USD1,406,823USD1,338,824USD1,242,325USD1,105,003USD
    Total Other Income Expense Net2,214,000USD2,310,732USD1,702,798USD553,104USD18,605USD139,213USD395,912USD193,537USD
    Interest Expense———581,852USD18,605USD139,213USD395,912USD0USD
    Non Operating Income Net Other———553,104USD18,605USD139,213USD395,912USD193,537USD
    Net Income Applicable To Common Shares———12,828,487USD9,325,471USD1,369,001USD9,630,959USD6,303,450USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets114,975,000USD114,389,000USD108,776,000USD114,721,779USD106,447,489USD101,729,435USD98,325,775USD94,246,761USD
    Cash And Equivalents59,080,000USD———————
    Total Current Assets86,722,000USD86,422,000USD81,203,000USD84,919,005USD77,372,612USD75,136,765USD75,242,219USD74,286,227USD
    Other Current Assets1,401,000USD4,750,000USD4,757,000USD2,799,740USD2,254,361USD1,543,964USD2,049,690USD948,841USD
    Other Non Current Assets244,000USD———————
    Total Liabilities13,227,000USD———————
    Total Current Liabilities9,164,000USD12,118,000USD10,180,000USD12,796,917USD8,814,546USD8,473,444USD8,512,308USD8,063,010USD
    Total Stockholder Equity101,748,000USD98,514,000USD94,618,000USD98,351,971USD94,301,386USD90,054,430USD86,818,756USD83,432,625USD
    Total Equity Including Noncontrolling Interest101,748,000USD———————
    Deferred Revenue3,469,000USD———————
    Deferred Revenue Non Current4,063,000USD———————
    Net Receivables13,192,000USD13,415,000USD13,667,000USD13,858,292USD10,922,134USD12,706,192USD10,556,733USD10,364,786USD
    Inventory12,257,000USD11,883,000USD11,620,000USD11,734,822USD11,200,336USD10,555,729USD10,401,889USD11,251,549USD
    Property Plant Equipment Net24,208,000USD24,225,000USD23,856,000USD23,792,441USD22,938,080USD20,437,016USD16,965,485USD14,420,060USD
    Accounts Payable1,849,000USD2,182,000USD1,820,000USD2,333,474USD1,900,980USD2,590,044USD1,896,405USD1,400,544USD
    Common Stock1,000USD1,000USD1,000USD1,272USD1,272USD1,272USD1,271USD1,267USD
    Retained Earnings70,154,000USD67,493,000USD64,230,999USD66,343,052USD62,928,991USD59,316,658USD56,790,751USD53,545,271USD
    Intangible Assets—3,286,000USD3,384,000USD3,373,478USD3,374,945USD3,258,759USD3,098,691USD2,891,657USD
    Total Liab—15,875,000USD14,158,000USD16,369,808USD12,146,103USD11,675,005USD11,507,019USD10,814,136USD
    Other Current Liab—6,539,000USD5,489,000USD4,208,201USD3,331,366USD2,385,242USD4,040,025USD3,652,429USD
    Capital Stock—1,000USD1,000USD1,272USD1,272USD1,272USD1,271USD1,267USD
    Cash—56,374,000USD51,159,000USD56,526,151USD52,995,781USD50,330,880USD52,233,907USD51,721,051USD
    Cash And Short Term Investments—56,374,000USD51,159,000USD56,526,151USD52,995,781USD50,330,880USD52,233,907USD51,721,051USD
    Current Deferred Revenue—3,397,000USD2,871,000USD3,158,065USD3,257,556USD2,598,549USD2,259,616USD2,555,105USD
    Net Debt—-56,374,000USD-51,159,000USD-56,526,151USD-52,995,781USD-50,271,659USD-52,079,219USD-51,456,976USD
    Property Plant Equipment Gross—29,588,000USD28,928,000USD28,658,956USD27,785,777USD25,166,878USD21,560,992USD18,880,217USD
    Common Stock Shares Outstanding—12,870,000shares12,875,000shares12,860,077shares12,830,480shares12,825,672shares12,783,558shares12,778,446shares
    Non Current Assets Total—27,967,000USD27,572,999USD29,802,774USD29,074,877USD26,592,670USD23,083,556USD19,960,534USD
    Non Current Liabilities Total—3,757,000USD3,977,999USD3,572,891USD3,331,557USD3,201,561USD2,994,711USD2,751,126USD
    Non Currrent Assets Other—225,000USD238,999USD214,374USD204,499USD206,009USD198,912USD184,213USD
    Net Working Capital—74,304,000USD71,023,000USD72,122,088USD68,558,066USD66,663,321USD66,729,911USD66,223,217USD
    Unclassified Non Current Liabilities—3,757,000USD3,977,999USD3,572,891USD3,331,557USD3,201,561USD2,994,711USD2,751,126USD
    Unclassified Equity—31,019,000USD30,385,001USD32,006,375USD31,369,851USD30,735,228USD30,025,463USD29,884,820USD
    Unclassified Non Current Assets———2,422,481USD2,557,353USD2,690,886USD2,820,468USD2,464,604USD
    Unclassified Current Liabilities———3,097,177USD————
    Short Term Debt—————59,221USD153,264USD261,244USD
    Short Long Term Debt Total—————59,221USD154,688USD264,075USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets108,776,000USD98,325,775USD92,156,098USD85,513,747USD82,881,422USD71,066,620USD66,728,864USD48,442,258USD
    Intangible Assets3,384,000USD3,098,691USD2,519,053USD2,069,439USD1,118,584USD960,885USD860,087USD832,519USD
    Other Current Assets4,757,000USD2,049,690USD1,193,447USD885,053USD4,307,154USD3,248,877USD1,778,749USD1,894,679USD
    Total Liab14,158,000USD11,507,019USD20,735,934USD11,840,760USD10,707,616USD9,682,008USD11,204,469USD6,496,525USD
    Total Stockholder Equity94,618,000USD86,818,756USD71,420,164USD73,672,987USD72,173,806USD61,384,612USD55,524,395USD41,945,733USD
    Other Current Liab5,489,000USD4,040,025USD11,118,563USD2,965,920USD3,069,875USD1,951,271USD2,356,391USD1,985,266USD
    Common Stock1,000USD1,271USD1,265USD1,259USD1,254USD1,231USD1,177USD1,099USD
    Capital Stock1,000USD1,271USD1,265USD1,259USD1,254USD1,231USD1,177USD1,099USD
    Retained Earnings64,230,999USD56,790,751USD43,258,154USD47,264,282USD46,994,922USD37,669,451USD36,300,450USD26,669,491USD
    Cash51,159,000USD52,233,907USD49,762,198USD57,960,864USD61,999,550USD50,068,728USD43,481,781USD28,027,688USD
    Cash And Short Term Investments51,159,000USD52,233,907USD49,762,198USD57,960,864USD62,501,405USD51,978,096USD46,250,068USD34,377,603USD
    Total Current Assets81,203,000USD75,242,219USD76,001,112USD77,489,671USD76,244,957USD63,735,892USD58,963,681USD44,541,717USD
    Total Current Liabilities10,180,000USD8,512,308USD16,327,306USD8,553,743USD6,822,757USD4,917,263USD5,858,972USD4,689,520USD
    Current Deferred Revenue2,871,000USD2,259,616USD2,570,407USD3,373,122USD2,553,096USD1,949,259USD1,671,420USD1,798,784USD
    Net Debt-51,159,000USD-52,079,219USD-47,719,155USD-55,755,578USD-59,517,466USD-47,353,698USD-40,525,908USD-28,027,688USD
    Net Receivables13,667,000USD10,556,733USD12,224,273USD13,274,521USD5,136,599USD4,574,932USD7,293,303USD4,209,992USD
    Inventory11,620,000USD10,401,889USD12,821,194USD5,369,233USD4,299,799USD3,933,987USD3,641,561USD4,059,443USD
    Accounts Payable1,820,000USD1,896,405USD1,857,091USD1,799,316USD782,903USD657,054USD993,742USD772,470USD
    Property Plant Equipment Net23,856,000USD16,965,485USD11,331,668USD4,605,098USD4,551,460USD4,835,178USD5,009,679USD1,869,561USD
    Property Plant Equipment Gross28,928,000USD21,560,992USD15,401,503USD8,035,428USD4,551,460USD4,835,178USD5,009,679USD1,869,561USD
    Common Stock Shares Outstanding12,854,000shares12,783,558shares12,722,530shares12,635,971shares12,590,853shares12,440,086shares12,276,444shares12,110,117shares
    Non Current Assets Total27,572,999USD23,083,556USD16,154,986USD8,024,076USD6,636,465USD7,330,728USD7,765,183USD3,900,541USD
    Non Current Liabilities Total3,977,999USD2,994,711USD4,408,628USD3,287,017USD3,884,859USD4,764,745USD5,345,497USD1,807,005USD
    Non Currrent Assets Other238,999USD198,912USD181,449USD648,672USD201,325USD261,993USD232,002USD109,759USD
    Net Working Capital71,023,000USD66,729,911USD59,673,806USD69,635,709USD69,422,200USD58,818,629USD53,104,709USD39,852,197USD
    Unclassified Non Current Liabilities3,977,999USD2,994,711USD4,408,628USD-1,375,197USD-1,679,343USD-2,305,413USD-2,630,467USD-1,807,005USD
    Unclassified Equity30,385,001USD30,025,463USD28,159,480USD26,406,187USD25,159,364USD23,675,612USD19,191,217USD15,316,236USD
    Short Term Debt—153,264USD427,963USD293,466USD276,568USD255,698USD240,843USD133,000USD
    Short Long Term Debt Total—154,688USD2,043,043USD2,205,286USD2,482,084USD2,715,030USD2,955,873USD—
    Unclassified Non Current Assets—2,820,468USD2,122,815USD——-5,097,171USD——
    Other Assets——1USD1,349,539USD966,421USD6,369,843USD1,895,417USD1,198,461USD
    Other Liab———1,375,197USD1,679,343USD2,305,413USD2,630,467USD1,807,005USD
    Short Term Investments———0USD501,855USD1,909,368USD2,768,287USD6,349,915USD
    Non Current Liabilities Other———3,287,017USD3,884,859USD4,764,745USD5,345,497USD1,807,005USD
    Net Tangible Assets———71,603,548USD71,055,222USD60,423,727USD54,664,308USD41,113,214USD
    Accumulated Other Comprehensive Income————17,012USD37,087USD30,374USD-42,192USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Net Income5,218,000USD5,818,000USD6,441,958USD5,576,652USD5,773,961USD4,687,429USD5,146,778USD5,049,491USD
    Stock Based Compensation640,000USD684,000USD696,236USD666,082USD730,618USD826,064USD656,835USD629,964USD
    Operating Cash Flow7,746,000USD———————
    Capital Expenditures-2,824,000USD-403,000USD-482,166USD-1,137,614USD-2,823,738USD-3,697,468USD-3,056,729USD-4,011,484USD
    Depreciation—455,000USD380,680USD383,722USD207,476USD194,122USD194,866USD197,571USD
    Other Non Cash Items—55,000USD2,217,785USD667,983USD28,421USD76,954USD-117,637USD-12,499USD
    Change To Account Receivables—212,000USD191,434USD-2,885,922USD1,802,037USD-2,134,549USD-188,810USD1,698,484USD
    Change To Inventory—-534,000USD53,911USD-559,684USD-751,217USD-120,010USD1,847,838USD699,521USD
    Change In Working Capital—1,415,000USD-3,947,620USD222,845USD872,252USD-1,492,477USD212,050USD3,125,357USD
    Total Cash From Operating Activities—8,290,000USD5,922,572USD6,986,074USD7,746,261USD4,292,092USD5,987,069USD9,115,714USD
    Free Cash Flow—7,887,000USD5,440,406USD5,848,460USD4,922,523USD594,624USD2,930,340USD5,104,230USD
    Total Cashflows From Investing Activities—-469,000USD-416,407USD-1,263,555USD-2,823,738USD-3,917,300USD-3,056,729USD-4,011,484USD
    Total Cash From Financing Activities—-2,606,000USD-10,873,409USD-2,192,150USD-2,257,622USD-2,277,819USD-2,417,484USD-1,918,319USD
    Dividends Paid—-2,556,000USD-8,554,259USD-2,162,591USD-2,161,628USD-2,161,522USD-1,901,298USD-1,900,487USD
    Change In Cash—5,215,000USD-5,367,151USD3,530,370USD2,664,901USD-1,903,027USD512,856USD3,185,911USD
    Begin Period Cash Flow—51,159,000USD56,526,151USD52,995,781USD50,330,880USD52,233,907USD51,721,051USD48,535,140USD
    End Period Cash Flow—56,374,000USD51,159,000USD56,526,151USD52,995,781USD50,330,880USD52,233,907USD51,721,051USD
    Other Cashflows From Investing Activities—-66,000USD-122,233USD-125,943USD-187,992USD-219,832USD-266,555USD-201,462USD
    Other Cashflows From Financing Activities—-50,000USD-2,319,150USD-29,559USD-95,994USD-116,297USD-542,508USD-17,832USD
    Investments———-1,263,555USD-2,823,738USD-3,917,300USD-3,056,729USD-4,011,484USD
    Unclassified Investing Cash Flow———1,263,557USD3,011,730USD3,917,300USD3,323,284USD4,212,946USD
    Sale Purchase Of Stock———————63,876USD
    SourceDisclosurePreliminaryAmendmentLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income22,480,000USD19,234,026USD17,192,776USD12,828,487USD9,325,471USD1,369,000USD9,630,959USD6,303,450USD
    Depreciation1,166,000USD817,656USD765,180USD670,673USD1,406,823USD1,338,824USD1,242,325USD1,105,003USD
    Stock Based Compensation2,919,000USD2,524,536USD2,186,909USD1,394,106USD1,459,373USD3,962,021USD1,854,965USD1,764,319USD
    Other Non Cash Items2,727,000USD-3,023USD402,317USD148,738USD119,044USD-70,069USD68,688USD155,659USD
    Change To Account Receivables-3,027,000USD1,762,075USD841,911USD-8,240,688USD-575,543USD2,690,487USD-3,114,649USD-446,896USD
    Change To Inventory-1,377,000USD3,126,046USD-7,468,170USD-1,308,956USD-393,316USD-282,904USD123,680USD-121,591USD
    Change In Working Capital-4,345,000USD3,748,920USD-5,910,262USD-5,056,390USD-1,576,162USD-1,172,212USD-1,967,449USD-1,807,986USD
    Total Cash From Operating Activities24,947,000USD25,624,463USD13,465,012USD10,042,711USD11,258,156USD5,817,496USD10,232,733USD7,376,015USD
    Capital Expenditures-7,765,000USD-8,005,033USD-8,007,167USD-1,874,997USD-741,759USD-636,746USD-485,812USD-264,665USD
    Free Cash Flow17,182,000USD17,619,430USD5,457,845USD8,167,714USD10,516,397USD5,180,750USD9,746,921USD7,111,350USD
    Total Cashflows From Investing Activities-8,421,000USD-8,816,786USD-8,007,167USD-1,374,997USD648,241USD246,969USD3,201,188USD1,515,823USD
    Total Cash From Financing Activities-17,601,000USD-14,335,968USD-13,656,511USD-12,706,400USD24,425USD522,482USD2,020,172USD929,874USD
    Dividends Paid-15,040,000USD-13,677,426USD-13,222,907USD-12,559,127USD-12,559,127USD-12,559,127USD-12,559,127USD—
    Change In Cash-1,075,000USD2,471,709USD-8,198,666USD-4,038,686USD11,930,822USD6,586,947USD15,454,093USD9,821,712USD
    Begin Period Cash Flow52,234,000USD49,762,198USD57,960,864USD61,999,550USD50,068,728USD43,481,781USD28,027,688USD18,205,976USD
    End Period Cash Flow51,159,000USD52,233,907USD49,762,198USD57,960,864USD61,999,550USD50,068,728USD43,481,781USD28,027,688USD
    Other Cashflows From Investing Activities-656,000USD-811,753USD-566,657USD-1,051,978USD-259,434USD689,972USD-117,531USD-36,350USD
    Other Cashflows From Financing Activities-2,561,000USD-688,160USD-433,604USD-147,273USD24,425USD-1,207,618USD2,020,172USD929,874USD
    Investments—-8,816,786USD-7,846,027USD500,000USD1,390,000USD883,715USD3,687,000USD1,780,488USD
    Unclassified Investing Cash Flow—8,816,786USD8,412,684USD1,051,978USD————
    Sale Purchase Of Stock——-610,348USD146,708USD-598,817USD-1,207,618USD-473,143USD-309,561USD
    Unclassified Operating Cash Flow——-1,171,908USD—————
    Change To Liabilities———4,069,816USD78,476USD-2,415,839USD973,728USD-905,274USD
    Cash And Cash Equivalents Changes———-4,038,686USD11,930,822USD6,586,947USD15,454,093USD9,821,712USD
    Unclassified Financing Cash Flow————13,157,944USD15,496,845USD13,032,270USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyInternational3,745,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States16,721,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductAmortized Revenue758,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductDevice Revenue — Ferro Magnetic Detection Systems756,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductDevice Revenue — MRICompatible IVInfusion Pumps6,428,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductDevice Revenue — MRICompatible Patient Vital Signs Monitoring Systems6,665,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductDisposable Revenue4,793,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductServices1,066,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyInternational3,954,000USD0001628280-26-029325
    Q1 2026Quarterly · 2026-03-31GeographyUnited States18,025,000USD0001628280-26-029325
    Q1 2026Quarterly · 2026-03-31ProductAmortized Revenue659,000USD0001628280-26-029325
    Q1 2026Quarterly · 2026-03-31ProductDevice Revenue — Ferro Magnetic Detection Systems621,000USD0001628280-26-029325
    Q1 2026Quarterly · 2026-03-31ProductDevice Revenue — MRICompatible IVInfusion Pumps7,664,000USD0001628280-26-029325
    Q1 2026Quarterly · 2026-03-31ProductDevice Revenue — MRICompatible Patient Vital Signs Monitoring Systems7,107,000USD0001628280-26-029325
    Q1 2026Quarterly · 2026-03-31ProductDisposable Revenue4,885,000USD0001628280-26-029325
    Q1 2026Quarterly · 2026-03-31ProductServices1,043,000USD0001628280-26-029325
    FY 2025Yearly · 2025-12-31GeographyInternational13,256,000USD0001104659-26-024691
    FY 2025Yearly · 2025-12-31GeographyUnited States70,558,000USD0001104659-26-024691
    Q3 2025Quarterly · 2025-09-30GeographyInternational3,087,068USD0001104659-25-105538
    Q3 2025Quarterly · 2025-09-30GeographyUnited States18,114,996USD0001104659-25-105538
    Q2 2025Quarterly · 2025-06-30GeographyInternational2,219,337USD0001558370-25-009987
    Q2 2025Quarterly · 2025-06-30GeographyUnited States18,190,063USD0001558370-25-009987
    Q1 2025Quarterly · 2025-03-31GeographyInternational3,558,000USD0001628280-26-029325
    Q1 2025Quarterly · 2025-03-31GeographyUnited States15,953,000USD0001628280-26-029325
    Q1 2025Quarterly · 2025-03-31ProductAmortized Revenue560,000USD0001628280-26-029325
    Q1 2025Quarterly · 2025-03-31ProductDevice Revenue — Ferro Magnetic Detection Systems418,000USD0001628280-26-029325
    Q1 2025Quarterly · 2025-03-31ProductDevice Revenue — MRICompatible IVInfusion Pumps5,999,000USD0001628280-26-029325
    Q1 2025Quarterly · 2025-03-31ProductDevice Revenue — MRICompatible Patient Vital Signs Monitoring Systems6,545,000USD0001628280-26-029325
    Q1 2025Quarterly · 2025-03-31ProductDisposable Revenue4,947,000USD0001628280-26-029325
    Q1 2025Quarterly · 2025-03-31ProductServices1,042,000USD0001628280-26-029325
    Q4 2024Quarterly · 2024-12-31GeographyInternational2,883,650USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States16,505,517USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyInternational12,635,000USD0001104659-26-024691
    FY 2024Yearly · 2024-12-31GeographyUnited States60,607,000USD0001104659-26-024691
    Q3 2024Quarterly · 2024-09-30GeographyInternational3,118,764USD0001104659-25-105538
    Q3 2024Quarterly · 2024-09-30GeographyUnited States15,207,195USD0001104659-25-105538
    Q2 2024Quarterly · 2024-06-30GeographyInternational2,443,660USD0001558370-25-009987
    Q2 2024Quarterly · 2024-06-30GeographyUnited States15,485,216USD0001558370-25-009987
    FY 2023Yearly · 2023-12-31GeographyInternational13,036,847USD0001558370-25-002389
    FY 2023Yearly · 2023-12-31GeographyUnited States52,525,449USD0001558370-25-002389
    FY 2022Yearly · 2022-12-31GeographyInternational9,404,410USD0001558370-24-002235
    FY 2022Yearly · 2022-12-31GeographyUnited States43,898,735USD0001558370-24-002235
    FY 2021Yearly · 2021-12-31GeographyInternational8,351,922USD0001104659-23-028003
    FY 2021Yearly · 2021-12-31GeographyUnited States33,462,659USD0001104659-23-028003
    FY 2020Yearly · 2020-12-31GeographyInternational7,181,929USD0001104659-22-030317
    FY 2020Yearly · 2020-12-31GeographyUnited States24,535,443USD0001104659-22-030317
    FY 2019Yearly · 2019-12-31GeographyInternational7,586,874USD0001104659-22-030317
    FY 2019Yearly · 2019-12-31GeographyUnited States30,930,267USD0001104659-22-030317
    FY 2018Yearly · 2018-12-31GeographyInternational5,930,957USD0001104659-21-032380
    FY 2018Yearly · 2018-12-31GeographyUnited States24,508,026USD0001104659-21-032380
    Q4 2017Quarterly · 2017-12-31ProductDevices — Mri Compatible Patient Vital Signs Monitoring Systems940,994USDLegacy provider
    Q4 2017Quarterly · 2017-12-31ProductDevices — MRICompatible IVInfusion Pumps3,733,603USDLegacy provider
    Q4 2017Quarterly · 2017-12-31ProductDisposable IVSets And Services2,030,347USDLegacy provider
    FY 2017Yearly · 2017-12-31ProductDevices — Mri Compatible Patient Vital Signs Monitoring Systems1,848,616USD0001104659-18-015709
    FY 2017Yearly · 2017-12-31ProductDevices — MRICompatible IVInfusion Pumps13,621,769USD0001104659-18-015709
    FY 2017Yearly · 2017-12-31ProductDisposable IVSets And Services7,611,207USD0001104659-18-015709
    Q3 2017Quarterly · 2017-09-30ProductDevices — Mri Compatible Patient Vital Signs Monitoring Systems118,598USD0001104659-17-066294
    Q3 2017Quarterly · 2017-09-30ProductDevices — MRICompatible IVInfusion Pumps3,606,327USD0001104659-17-066294
    Q3 2017Quarterly · 2017-09-30ProductDisposable IVSets And Services1,964,799USD0001104659-17-066294
    Q2 2017Quarterly · 2017-06-30ProductDevices — Mri Compatible Patient Vital Signs Monitoring Systems399,322USD0001104659-17-049429
    Q2 2017Quarterly · 2017-06-30ProductDevices — MRICompatible IVInfusion Pumps3,279,228USD0001104659-17-049429
    Q2 2017Quarterly · 2017-06-30ProductDisposable IVSets And Services1,845,814USD0001104659-17-049429
    Q1 2017Quarterly · 2017-03-31ProductDevices — Mri Compatible Patient Vital Signs Monitoring Systems389,702USD0001104659-17-030037
    Q1 2017Quarterly · 2017-03-31ProductDevices — MRICompatible IVInfusion Pumps3,002,611USD0001104659-17-030037
    Q1 2017Quarterly · 2017-03-31ProductDisposable IVSets And Services1,770,247USD0001104659-17-030037
    FY 2016Yearly · 2016-12-31ProductDevices — Mri Compatible Patient Vital Signs Monitoring Systems293,552USD0001104659-18-015709
    FY 2016Yearly · 2016-12-31ProductDevices — MRICompatible IVInfusion Pumps25,491,720USD0001104659-18-015709
    FY 2016Yearly · 2016-12-31ProductDisposable IVSets And Services6,711,276USD0001104659-18-015709
    Q3 2016Quarterly · 2016-09-30ProductDevices — Mri Compatible Patient Vital Signs Monitoring Systems122,074USD0001104659-17-066294
    Q3 2016Quarterly · 2016-09-30ProductDevices — MRICompatible IVInfusion Pumps5,890,612USD0001104659-17-066294
    Q3 2016Quarterly · 2016-09-30ProductDisposable IVSets And Services1,660,531USD0001104659-17-066294
    FY 2015Yearly · 2015-12-31ProductDevices — Mri Compatible Patient Vital Signs Monitoring Systems26,780USD0001104659-18-015709
    FY 2015Yearly · 2015-12-31ProductDevices — MRICompatible IVInfusion Pumps26,326,455USD0001104659-18-015709
    FY 2015Yearly · 2015-12-31ProductDisposable IVSets And Services5,240,485USD0001104659-18-015709
    FY 2014Yearly · 2014-12-31ProductDevices12,812,446USD0001104659-16-104068
    FY 2014Yearly · 2014-12-31ProductDisposable IVSets And Services2,840,611USD0001104659-16-104068
    FY 2013Yearly · 2013-12-31ProductDevices9,335,753USD0001104659-15-021769
    FY 2013Yearly · 2013-12-31ProductDisposable IVSets And Services2,004,344USD0001104659-15-021769

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.